Literature DB >> 2981446

Tumorigenic poxviruses: genomic organization of malignant rabbit virus, a recombinant between Shope fibroma virus and myxoma virus.

W Block, C Upton, G McFadden.   

Abstract

The genome of malignant rabbit virus (MRV), a newly discovered tumorigenic poxvirus of rabbits, has been analyzed using cloned DNA probes from Shope fibroma virus (SFV) and myxoma virus. Under high stringency conditions for Southern blotting such that SFV probes do not cross-hybridize with myxoma virus DNA, it is demonstrated that greater than 90% of the MRV genome has been derived from myxoma virus, and that approximately 10 kb of SFV-derived sequences have substituted for a similar amount of myxoma sequences. Mapping of the MRV genome indicates that the SFV sequences are present in two regions of the genome, one in each copy of the MRV terminal inverted repeat sequence. Furthermore, fine mapping studies of the integration sites for SFV into the myxoma background show that these SFV sequences are not symmetrical with respect to the left and right genomic termini. At the left end, 4 kb of SFV-derived DNA maps between 6 and 10 kb from the terminus, while at the right end about 5.5 kb of SFV sequences are found to extend at least 1 kb further toward the unique internal sequences. Based on this asymmetrical bipartite distribution of SFV sequences in MRV, a two-stage model to rationalize the origin of MRV is proposed. This model postulates an initial recombination event similar to gene conversion between myxoma and SFV at the right terminus of myxoma, followed by an incomplete transposition of only part of these SFV sequences to the left terminus.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981446     DOI: 10.1016/0042-6822(85)90450-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

1.  The genome of Shope fibroma virus, a tumorigenic poxvirus, contains a growth factor gene with sequence similarity to those encoding epidermal growth factor and transforming growth factor alpha.

Authors:  W Chang; C Upton; S L Hu; A F Purchio; G McFadden
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

2.  DNA sequence homology between the terminal inverted repeats of Shope fibroma virus and an endogenous cellular plasmid species.

Authors:  C Upton; G McFadden
Journal:  Mol Cell Biol       Date:  1986-01       Impact factor: 4.272

3.  Inhibition of epidermal growth factor-induced cellular proliferation.

Authors:  D S Strayer; J L Leibowitz
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

4.  Identification and nucleotide sequence of the thymidine kinase gene of Shope fibroma virus.

Authors:  C Upton; G McFadden
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

5.  Inhibition of virus replication does not alter malignant rabbit fibroma virus-induced immunosuppression.

Authors:  D S Strayer; E Skaletsky; J L Leibowitz
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

6.  Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor.

Authors:  A Opgenorth; K Graham; N Nation; D Strayer; G McFadden
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

7.  Genomic characterization of a poxvirus isolated from a child.

Authors:  A Rösen; J Pilaski; G Darai
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

Review 8.  Poxvirus pathogenesis.

Authors:  R M Buller; G J Palumbo
Journal:  Microbiol Rev       Date:  1991-03

9.  Comparative analysis of the complete genome sequence of the California MSW strain of myxoma virus reveals potential host adaptations.

Authors:  Peter J Kerr; Matthew B Rogers; Adam Fitch; Jay V Depasse; Isabella M Cattadori; Peter J Hudson; David C Tscharke; Edward C Holmes; Elodie Ghedin
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

10.  DNA strand exchange catalyzed by proteins from vaccinia virus-infected cells.

Authors:  W Zhang; D H Evans
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.